The pathogenesis of inflammatory bowel disease (ulcerative colitis and Crohn's disease) has not been resolved despite numerous studies. A major drawback has been the lack of suitable animal models. Recently mice mutant for T cell receptor (TCR) and RAG-1 genes have been created by gene targeting in embryonic stem cells. We have determined that mice mutant for TCRalpha or TCRbeta genes but not for TCRdelta or the RAG-1 genes, develop an inflammatory bowel disease, which is restricted to the rectum and colon and resembles ulcerative colitis. We propose to develop colonies of mice mutant for TCRalpha, beta or delta, and RAG-1 genes, using the animal facilities at the Massachusetts General Hospital. Studies performed on colonies of these mutant mice will permit evaluation of the role of various T and B cell subsets and natural killer cells in the development of inflammatory bowel disease. We will document the incidence and progression of the disease and identify factors associated with the disease process. The studies will include histological and immunohistological examination of tissues, flow cytometric and functional characterization of inflammatory cells in the colon and rectum and detection of autoantibodies in the sera of the diseased animals. This project will focus on the hypothesis that an abnormality of immunoregulatory T cells at the mucosal sites leads to altered immune response to luminal antigens resulting in mucosal injury, possibly due to autoimmune mechanisms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK047677-01A1
Application #
2147472
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1994-09-15
Project End
1997-08-31
Budget Start
1994-09-15
Budget End
1995-08-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Manocha, Monika; Rietdijk, Svend; Svend, Rietdijk et al. (2009) Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis. J Immunol 183:270-6
Shimomura, Yasuyo; Mizoguchi, Emiko; Sugimoto, Ken et al. (2008) Regulatory role of B-1 B cells in chronic colitis. Int Immunol 20:729-37
Nanno, Masanobu; Kanari, Yasuyoshi; Naito, Tomoaki et al. (2008) Exacerbating role of gammadelta T cells in chronic colitis of T-cell receptor alpha mutant mice. Gastroenterology 134:481-90
Shimomura, Yasuyo; Ogawa, Atsuhiro; Kawada, Mayumi et al. (2008) A unique B2 B cell subset in the intestine. J Exp Med 205:1343-55
Sugimoto, Ken; Ogawa, Atsuhiro; Mizoguchi, Emiko et al. (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118:534-44
Nguyen, Deanna D; Maillard, Michel H; Cotta-de-Almeida, Vinicius et al. (2007) Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein. Gastroenterology 133:1188-97
Yuan, Qian; Bromley, Shannon K; Means, Terry K et al. (2007) CCR4-dependent regulatory T cell function in inflammatory bowel disease. J Exp Med 204:1327-34
Mizoguchi, Atsushi; Ogawa, Atsushiro; Takedatsu, Hidetoshi et al. (2007) Dependence of intestinal granuloma formation on unique myeloid DC-like cells. J Clin Invest 117:605-15
Sugimoto, Ken; Ogawa, Atsuhiro; Shimomura, Yasuyo et al. (2007) Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation. Gastroenterology 133:124-36
Maillard, Michel H; Cotta-de-Almeida, Vinicius; Takeshima, Fuminao et al. (2007) The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med 204:381-91

Showing the most recent 10 out of 53 publications